Consensus statement
Consensus document on the implementation of next generation sequencing in the genetic diagnosis of hereditary cancer
Documento de consenso sobre la implementación de la secuenciación masiva de nueva generación en el diagnóstico genético de la predisposición hereditaria al cáncer
José Luis Sotoa, Ignacio Blancob, Orland Díezc, Javier García Planellsd, Isabel Lordae,f, Gert Matthijsg, Mercedes Robledoh,f, Erika Soucheg, Conxi Lázaroi,
Corresponding author
a Molecular Genetics Laboratory, Elche University General Hospital, Alicante Institute for Health and Biomedical Research, Alicante, Spain
b Clinical Genetics and Genetic Counseling Program, Germans Trias i Pujol Hospital, Can Ruti Campus, Badalona, Barcelona, Spain
c Area of Clinical and Molecular Genetics, University Hospital Vall d’Hebron, and Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
d Instituto de Medicina Genómica, Paterna, Valencia, Spain
e Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Diaz (IIS-FJD), Madrid, Spain
f Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain
g Center for Human Genetics, KU Leuven, Gasthuisberg, Laboratory for Molecular Diagnosis, on behalf of the EuroGentest/ESHG Working Group on Diagnostic NGS, Leuven, Belgium
h Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre, Madrid, Spain
i Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain
Ver más